Validity of Meta-Analytical Data on Cutaneous Adverse Events with Phosphoinositide 3-Kinase Inhibitors-Reply
JAMA Oncol
.
2023 Oct 1;9(10):1462-1463.
doi: 10.1001/jamaoncol.2023.3387.
Authors
Abdulhadi Jfri
1
2
3
4
,
Lauren Guggina
1
2
3
Affiliations
1
Harvard Medical School, Boston, Massachusetts.
2
Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
3
Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
4
College of Medicine, King Saud bin Abdulaziz Univer for Health Sciences, Jeddah, Saudi Arabia.
PMID:
37651132
DOI:
10.1001/jamaoncol.2023.3387
No abstract available